1. Home
  2. RANI vs FPAY Comparison

RANI vs FPAY Comparison

Compare RANI & FPAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RANI
  • FPAY
  • Stock Information
  • Founded
  • RANI 2012
  • FPAY 2003
  • Country
  • RANI United States
  • FPAY United States
  • Employees
  • RANI N/A
  • FPAY N/A
  • Industry
  • RANI Medicinal Chemicals and Botanical Products
  • FPAY Diversified Commercial Services
  • Sector
  • RANI Health Care
  • FPAY Consumer Discretionary
  • Exchange
  • RANI Nasdaq
  • FPAY Nasdaq
  • Market Cap
  • RANI 28.1M
  • FPAY 28.7M
  • IPO Year
  • RANI 2021
  • FPAY N/A
  • Fundamental
  • Price
  • RANI $0.55
  • FPAY $1.41
  • Analyst Decision
  • RANI Strong Buy
  • FPAY Strong Buy
  • Analyst Count
  • RANI 5
  • FPAY 2
  • Target Price
  • RANI $8.20
  • FPAY $3.25
  • AVG Volume (30 Days)
  • RANI 885.8K
  • FPAY 44.7K
  • Earning Date
  • RANI 05-13-2025
  • FPAY 06-10-2025
  • Dividend Yield
  • RANI N/A
  • FPAY N/A
  • EPS Growth
  • RANI N/A
  • FPAY N/A
  • EPS
  • RANI N/A
  • FPAY N/A
  • Revenue
  • RANI $1,200,000.00
  • FPAY $139,800,732.00
  • Revenue This Year
  • RANI $24,705.45
  • FPAY $16.58
  • Revenue Next Year
  • RANI N/A
  • FPAY N/A
  • P/E Ratio
  • RANI N/A
  • FPAY N/A
  • Revenue Growth
  • RANI N/A
  • FPAY 19.51
  • 52 Week Low
  • RANI $0.46
  • FPAY $0.97
  • 52 Week High
  • RANI $5.74
  • FPAY $2.37
  • Technical
  • Relative Strength Index (RSI)
  • RANI 32.55
  • FPAY 59.65
  • Support Level
  • RANI $0.55
  • FPAY $1.15
  • Resistance Level
  • RANI $0.77
  • FPAY $1.44
  • Average True Range (ATR)
  • RANI 0.09
  • FPAY 0.07
  • MACD
  • RANI 0.01
  • FPAY 0.01
  • Stochastic Oscillator
  • RANI 33.44
  • FPAY 89.66

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

About FPAY FlexShopper Inc.

FlexShopper Inc is a financial technology company engaged in providing certain types of durable goods to consumers on a lease-to-own basis and providing lease-to-own (LTO) terms to consumers of third-party retailers and e-tailers. Its products include electronics, computers, furniture, mattresses, cameras and camcorders, audio, musical instruments, health, fitness and sports, video games, homes, gardens and tools, appliances, and vacuums on a payment, lease basis. The firm generates a majority of its revenue by leasing its products. The company enables consumers utilizing its e-commerce marketplace to shop for brand-name electronics, home furnishings, and other durable goods on a lease-to-own (LTO) basis.

Share on Social Networks: